Abdominal Pregnancy: Discussion, classification, and case presentation

W. F. Baldwin

1954-10-01

Abstract:

What problem does this paper attempt to address?

A novel loss-of-function KCNB1 gene variant in a twin with global developmental delay and seizures

Rían W. Manville,Claire L. Illeck,Cesar Santos,Richard Sidlow,Geoffrey W. Abbott

DOI: https://doi.org/10.3389/fncel.2024.1477989

2024-10-15

Frontiers in Cellular Neuroscience

Abstract:Human voltage-gated potassium (Kv) channels are expressed by a 40-member gene family that is essential for normal electrical activity and is closely linked to various excitability disorders. Function-altering sequence variants in the KCNB1 gene, which encodes the neuronally expressed Kv2.1 channel, are associated with neurodevelopmental disorders including developmental delay with or without epileptic activity. In this study, we describe a 40-month-old fraternal twin who presented with severe neurodevelopmental delay. Electroencephalogram recordings at 19 months of age revealed poor sleep architecture and the presence of multifocal epileptiform discharges. The individual's fraternal twin was neurotypical, and there was no family history of neurodevelopmental delay or seizures. Whole genome sequencing at 33 months of age for the proband revealed a de novo variant in KCNB1 [c.1154C > T/p.Pro385Leu], encoding a proline-to-leucine substitution at residue 385, in the extracellular region immediately preceding Kv2.1 transmembrane segment 6 (S6). Cellular electrophysiological analysis of the effects of the gene variant in heterologously expressed Kv2.1 demonstrated that homozygous Kv2.1-P385L channels were completely non-functional. Channels generated by a 50/50 expression of wild-type Kv2.1 and Kv2.1-P385L, designed to mimic the proband's heterozygous status, revealed a partially dominant-negative effect, resulting in an 81% reduction in current magnitude. The dramatic loss of function in Kv2.1 is the most likely cause of the severe developmental delay and seizure activity in the proband, further enriching our phenotypic understanding of KCNB1 developmental encephalopathies.

neurosciences
A Novel Mutation in KCNQ2 Gene Causes Benign Familial Neonatal Convulsions in a Chinese Family

BS Tang,HY Li,K Xia,J Hang,Q Pan,L Shen,ZG Long,GH Zhao,F Cai

DOI: https://doi.org/10.1016/j.jns.2004.03.001

IF: 4.4

2004-01-01

Journal of the Neurological Sciences

Abstract:Benign familial neonatal convulsions (BFNC) are a rare autosomal dominant inherited epilepsy syndrome. Two voltage-gated potassium channel genes, KCNQ2 on chromosome 20q13.3 and KCNQ3 on chromosome 8q24, have been identified as the genes responsible for benign familial neonatal convulsions. By linkage analysis and mutation analysis of KCNQ2 gene, we found a novel frameshift mutation of KCNQ2 gene, 1931delG , in a large Chinese family with benign familial neonatal convulsions. This mutation is located in the C-terminus of KCNQ2, in codon 644 predicting the replacement of the last 201 amino acids with a stretch of 257 amino acids showing a completely different sequence. An unusual clinical feature of this family is that the seizures of every patient did not remit until 12 to 18 months. This is the first report of KCNQ2 gene mutation in China.
Autosomal Dominant Sleep-Related Hypermotor Epilepsy Associated with a Novel Mutation of KCNT1.

Jinyu Lu,Gaohua Zhao,Dayao Lv,Lanxiao Cao,Guohua Zhao

DOI: https://doi.org/10.1515/tnsci-2022-0241

2022-01-01

Translational Neuroscience

Abstract:Autosomal dominant sleep-related hypermotor epilepsy (ADSHE) is characterized by severe sleep-related rigid hypermotor seizures. The pathogenic genes of ADSHE include genes encoding subunits of the neuronal nicotinic acetylcholine receptor, KCNT1, DEPDC5, NPRL2/3, CABP4, and CRH. Individuals with KCNT1-related ADSHE are more likely to develop seizures at a younger age, have cognitive comorbidity, and display psychiatric and behavioral problems. In this study, a 12-year-old Chinese girl was referred for genetic evaluation of grand mal seizures. She had paroxysmal convulsions of the limbs and loss of consciousness just after falling asleep without obvious triggers. A novel heterozygous missense mutation c.2797C > T (p.Arg933Cys) in exon 24 of the KCNT1 was identified in the proband by whole-exome sequencing and Sanger sequencing, and the clinical symptoms were compatible with ADSHE. The proband’s father has been showing similar symptoms for more than 20 years and had the same site mutation. Her mother and sister were physically and genetically normal. The study revealed a novel variant in the KCNT1 and expanded the mutation spectrum for this clinical condition. Our results provide further evidence supporting a causative role in KCNT1 variants in ADSHE.
KCNQ1 Gain-of-function Mutation in Familial Atrial Fibrillation

YH Chen,SJ Xu,S Bendahhou,XL Wang,Y Wang,WY Xu,HW Jin,H Sun,XY Su,QN Zhuang,YQ Yang,YB Li,Y Liu,HJ Xu,XF Li,N Ma,CP Mou,Z Chen,J Barhanin,W Huang

DOI: https://doi.org/10.1126/science.1077771

2003-01-01

ACC Current Journal Review

Abstract:Atrial fibrillation (AF) is a common cardiac arrhythmia whose molecular etiology is poorly understood. We studied a family with hereditary persistent AF and identified the causative mutation (S140G) in the KCNQ1 (KvLQT1) gene on chromosome 11p15.5. The KCNQ1 gene encodes the pore-forming alpha subunit of the cardiac I(Ks) channel (KCNQ1/KCNE1), the KCNQ1/KCNE2 and the KCNQ1/KCNE3 potassium channels. Functional analysis of the S140G mutant revealed a gain-of-function effect on the KCNQ1/KCNE1 and the KCNQ1/KCNE2 currents, which contrasts with the dominant negative or loss-of-function effects of the KCNQ1 mutations previously identified in patients with long QT syndrome. Thus, the S140G mutation is likely to initiate and maintain AF by reducing action potential duration and effective refractory period in atrial myocytes.
Metabolism of 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(R)-HETE) in corneal tissues: formation of novel metabolites.

M. Nishimura,M. Schwartzman,J. Falck,S. Lumin,J. Zirrolli,R. Murphy

DOI: https://doi.org/10.1016/0003-9861(91)90548-W

IF: 4.114

1991-11-01

Archives of Biochemistry and Biophysics

Abstract:
A novel KCNQ2 missense variant in non-syndromic intellectual disability causes mild gain-of-function of Kv7.2 channel

Juan Xiong,Shimeng Chen,Baiyu Chen,Wen Zhang,Chen Chen,Xiaolu Deng,Fang He,Ciliu Zhang,Lifen Yang,Ying Wang,Jing Peng,Fei Yin

DOI: https://doi.org/10.1016/j.cca.2022.03.001

IF: 6.314

2022-05-01

Clinica Chimica Acta

Abstract:BACKGROUND: Heterozygous variants of KCNQ2 can cause KCNQ2 associated neurodevelopmental disorder, mainly are benign (familial) neonatal or infantile epilepsy (B(F)NE or B(F)IE) and developmental epileptic encephalopathy(DEE). Moreover, some intermediate phenotypes, including intellectual disability (ID), and myokymia are related to the gene.METHODS: We collected a non-syndromic ID male patient with a novel KCNQ2 missense variant. Whole cell electrophysiology, western blotting, and immunofluorescence were adopted to analyze the variant's functional alterations.RESULTS: The patient presented with global developmental delay since his infancy. He still had profound ID but did not have epilepsy at the adolescence. The de novo KCNQ2 variant p.R75C (NM_172107) in the NH2 domain identified here showed a slightly hyperpolarized shift of activation curves and larger current density in homomeric configurations, which could be abolished in co-expression with Kv7.2 or Kv7.3 wild-type. Western blotting and immunocytochemistry supported that the expression of variant p.R75C is lower than the Kv7.2 wild-type. The findings indicated variant p.R75C causes mild gain-of-function (GOF) of Kv7.2 channel.CONCLUSIONS: We report a non-syndromic ID patient with a KCNQ2 mild GOF variant, adding evidence for this rare clinical phenotype in the disorder. We propose that individuals with KCNQ2 GOF variants are prone to have cognitive impairments.

medical laboratory technology
A Novel Kv7.3 Variant in the Voltage-Sensing S4 Segment in a Family With Benign Neonatal Epilepsy: Functional Characterization and in vitro Rescue by β-Hydroxybutyrate

Francesco Miceli,Lidia Carotenuto,Vincenzo Barrese,Maria Virginia Soldovieri,Erin L Heinzen,Arthur M Mandel,Natalie Lippa,Louise Bier,David B Goldstein,Edward C Cooper,Maria Roberta Cilio,Maurizio Taglialatela,Tristan T Sands

DOI: https://doi.org/10.3389/fphys.2020.01040

2020-09-04

Abstract:Pathogenic variants in KCNQ2 and KCNQ3, paralogous genes encoding Kv7.2 and Kv7.3 voltage-gated K+ channel subunits, are responsible for early-onset developmental/epileptic disorders characterized by heterogeneous clinical phenotypes ranging from benign familial neonatal epilepsy (BFNE) to early-onset developmental and epileptic encephalopathy (DEE). KCNQ2 variants account for the majority of pedigrees with BFNE and KCNQ3 variants are responsible for a much smaller subgroup, but the reasons for this imbalance remain unclear. Analysis of additional pedigrees is needed to further clarify the nature of this genetic heterogeneity and to improve prediction of pathogenicity for novel variants. We identified a BFNE family with two siblings and a parent affected. Exome sequencing on samples from both parents and siblings revealed a novel KCNQ3 variant (c.719T>G; p.M240R), segregating in the three affected individuals. The M240 residue is conserved among human Kv7.2-5 and lies between the two arginines (R5 and R6) closest to the intracellular side of the voltage-sensing S4 transmembrane segment. Whole cell patch-clamp recordings in Chinese hamster ovary (CHO) cells revealed that homomeric Kv7.3 M240R channels were not functional, whereas heteromeric channels incorporating Kv7.3 M240R mutant subunits with Kv7.2 and Kv7.3 displayed a depolarizing shift of about 10 mV in activation gating. Molecular modeling results suggested that the M240R substitution preferentially stabilized the resting state and possibly destabilized the activated state of the Kv7.3 subunits, a result consistent with functional data. Exposure to β-hydroxybutyrate (BHB), a ketone body generated during the ketogenic diet (KD), reversed channel dysfunction induced by the M240R variant. In conclusion, we describe the first missense loss-of-function (LoF) pathogenic variant within the S4 segment of Kv7.3 identified in patients with BFNE. Studied under conditions mimicking heterozygosity, the M240R variant mainly affects the voltage sensitivity, in contrast to previously analyzed BFNE Kv7.3 variants that reduce current density. Our pharmacological results provide a rationale for the use of KD in patients carrying LoF variants in Kv7.2 or Kv7.3 subunits.
Mono-allelic KCNB2 variants lead to a neurodevelopmental syndrome caused by altered channel inactivation

Shreyas Bhat,Justine Rousseau,Coralie Michaud,Charles Marques Lourenço,Joan M. Stoler,Raymond J. Louie,Lola K. Clarkson,Angie Lichty,Daniel C. Koboldt,Shalini C. Reshmi,Sanjay M. Sisodiya,Eva M.M. Hoytema van Konijnenburg,Klaas Koop,Peter M. van Hasselt,Florence Démurger,Christèle Dubourg,Bonnie R. Sullivan,Susan S. Hughes,Isabelle Thiffault,Elisabeth Simard Tremblay,Andrea Accogli,Myriam Srour,Rikard Blunck,Philippe M. Campeau

DOI: https://doi.org/10.1016/j.ajhg.2024.02.014

2024-04-05

The American Journal of Human Genetics

Abstract:Channelopathies arise due to perturbations in ion channel function. In this study, we identify 10 variants in KCNB2 in individuals with neurodevelopmental disorders. Our data suggest that most KCNB2 variants show reduced potassium conductance due to either reduced functional expression or increased channel inactivation.

genetics & heredity
Impaired excitability of fast-spiking neurons in a novel mouse model of KCNC1 epileptic encephalopathy

Eric R Wengert,Melody A Cheng,Sophie R Liebergall,Kelly H Markwalter,Yerahm Hong,Leroy Arias,Eric D Marsh,Xiaohong Zhang,Ala Somarowthu,Ethan M Goldberg

DOI: https://doi.org/10.1101/2024.09.27.615463

2024-09-27

bioRxiv

Abstract:The recurrent pathogenic variant KCNC1-p.Ala421Val (A421V) is a cause of developmental and epileptic encephalopathy characterized by moderate-to-severe developmental delay/intellectual disability, and infantile-onset treatment-resistant epilepsy with multiple seizure types including myoclonic seizures. Yet, the mechanistic basis of disease is unclear. KCNC1 encodes Kv3.1, a voltage-gated potassium channel subunit that is highly and selectively expressed in neurons capable of generating action potentials at high frequency, including parvalbumin-positive fast-spiking GABAergic inhibitory interneurons in cerebral cortex (PV-INs) known to be important for cognitive function and plasticity as well as control of network excitation to prevent seizures. In this study, we generate a novel transgenic mouse model with conditional expression of the Ala421Val pathogenic missense variant (Kcnc1-A421V/+ mice) to explore the physiological mechanisms of KCNC1 developmental and epileptic encephalopathy. Our results indicate that global heterozygous expression of the A421V variant leads to epilepsy and premature lethality. We observe decreased PV-IN cell surface expression of Kv3.1 via immunohistochemistry, decreased voltage-gated potassium current density in PV-INs using outside-out nucleated macropatch recordings in brain slice, and profound impairments in the intrinsic excitability of cerebral cortex PV-INs but not excitatory neurons in current-clamp electrophysiology. In vivo two-photon calcium imaging revealed hypersynchronous discharges correlated with brief paroxysmal movements, subsequently shown to be myoclonic seizures on electroencephalography. We found alterations in PV-IN-mediated inhibitory neurotransmission in young adult but not juvenile Kcnc1-A421V/+ mice relative to wild-type controls. Together, these results establish the impact of the recurrent Kv3.1-A421V variant on neuronal excitability and synaptic physiology across development to drive network dysfunction underlying KCNC1 epileptic encephalopathy.
A KCNC1 Variant Linked to Rett Syndrome Disrupts ER to Golgi Trafficking of Kv3.1 Channel

Diego Maureira,Carla Rubilar,Joaquin Lopez,Paola Santander,Hans Moldenhauer,Ian Silva,Pablo Cruz,Denise Riquelme,Javiera Baeza,Wendy Gonzalez,Patricio Orio,Evrim Servili,Monica Troncoso,Elias Leiva-Salcedo,Oscar Cerda

DOI: https://doi.org/10.1101/2024.11.12.623225

2024-11-13

Abstract:Intrinsic neuronal excitability, defined by the balance between input and output signals, is crucial to neural function, and its disruption underlies various neurological diseases. Kv3.1 channels, encoded by KCNC1, are essential for high-frequency action potential firing. Variants in these channels are associated with several subtypes of epilepsy. We report a patient with developmental regression and epilepsy, meeting Rett syndrome criteria, who carries a KCNC1 variant encoding the S474C substitution in Kv3.1 (Kv3.1S474C). Electrophysiological and biochemical assays reveal that Kv3.1S474C reduces channel presence in the plasma membrane and is retained in the endoplasmic reticulum (ER). In murine primary cultures expressing Kv3.1S474C, we observed reduced neuronal firing frequency and exclusion of the channel from the axon initial segment (AIS). Consistently, we found a decreased firing frequency using a conductance-based computational neuronal model. In summary, this study identifies a novel link between a KCNC1 variant and Rett syndrome, highlighting the importance of S474 residue in Kv3.1 channel trafficking and function in neurons.

Cell Biology
Etiological involvement of KCND1 variants in an X-linked neurodevelopmental disorder with variable expressivity

Tassja Kalm,Claudia Schob,Hanna Völler,Thatjana Gardeitchik,Christian Gilissen,Rolph Pfundt,Chiara Klöckner,Konrad Platzer,Annick Klabunde-Cherwon,Markus Ries,Steffen Syrbe,Francesca Beccaria,Francesca Madia,Marcello Scala,Federico Zara,Floris Hofstede,Marleen E.H. Simon,Richard H. van Jaarsveld,Renske Oegema,Koen L.I. van Gassen,Sjoerd J.B. Holwerda,Tahsin Stefan Barakat,Arjan Bouman,Marjon van Slegtenhorst,Sara Álvarez,Alberto Fernández-Jaén,Javier Porta,Andrea Accogli,Margherita Maria Mancardi,Pasquale Striano,Michele Iacomino,Jong-Hee Chae,SeSong Jang,Soo Y. Kim,David Chitayat,Saadet Mercimek-Andrews,Christel Depienne,Antje Kampmeier,Alma Kuechler,Harald Surowy,Enrico Silvio Bertini,Francesca Clementina Radio,Cecilia Mancini,Simone Pizzi,Marco Tartaglia,Lucas Gauthier,David Genevieve,Mylène Tharreau,Noy Azoulay,Gal Zaks-Hoffer,Nesia K. Gilad,Naama Orenstein,Geneviève Bernard,Isabelle Thiffault,Jonas Denecke,Theresia Herget,Fanny Kortüm,Christian Kubisch,Robert Bähring,Stefan Kindler

DOI: https://doi.org/10.1016/j.ajhg.2024.04.019

2024-06-07

The American Journal of Human Genetics

Abstract:Hemizygous variants of KCND1 lead to alterations in the biophysical properties of the encoded ion channel, implicating dysfunction of Kv4.1 voltage-gated potassium channels in the etiology of an X-linked neurodevelopmental disorder with variable expressivity.

genetics & heredity
Electrophysiological Characterization Reveals a Complex Phenotype Affecting the Slow Delayed Rectifier Potassium Current (IKs) Voltage Dependence by Causing a Hyperpolarizing Shift and a Lack of Response to Protein Kinase A Activation

Antonia González-Garrido,Omar López-Ramírez,Abel Cerda-Mireles,Thania Navarrete-Miranda,Aranza Iztanami Flores-Arenas,Arturo Rojo-Domínguez,Leticia Arregui,Pedro Iturralde,Erika Antúnez-Argüelles,Mayra Domínguez-Pérez,Leonor Jacobo-Albavera,Alessandra Carnevale,Teresa Villarreal-Molina

DOI: https://doi.org/10.3390/ijms25020953

IF: 5.6

2024-01-12

International Journal of Molecular Sciences

Abstract:Genetic testing is crucial in inherited arrhythmogenic channelopathies; however, the clinical interpretation of genetic variants remains challenging. Incomplete penetrance, oligogenic, polygenic or multifactorial forms of channelopathies further complicate variant interpretation. We identified the KCNQ1/p.D446E variant in 2/63 patients with long QT syndrome, 30-fold more frequent than in public databases. We thus characterized the biophysical phenotypes of wildtype and mutant IKs co-expressing these alleles with the β-subunit minK in HEK293 cells. KCNQ1 p.446E homozygosity significantly shifted IKs voltage dependence to hyperpolarizing potentials in basal conditions (gain of function) but failed to shift voltage dependence to hyperpolarizing potentials (loss of function) in the presence of 8Br-cAMP, a protein kinase A activator. Basal IKs activation kinetics did not differ among genotypes, but in response to 8Br-cAMP, IKs 446 E/E (homozygous) activation kinetics were slower at the most positive potentials. Protein modeling predicted a slower transition of the 446E Kv7.1 tetrameric channel to the stabilized open state. In conclusion, biophysical and modelling evidence shows that the KCNQ1 p.D446E variant has complex functional consequences including both gain and loss of function, suggesting a contribution to the pathogenesis of arrhythmogenic phenotypes as a functional risk allele.

biochemistry & molecular biology,chemistry, multidisciplinary
Altered neurological and neurobehavioral phenotypes in a mouse model of the recurrent KCNB1-p.R306C voltage-sensor variant

Seok Kyu Kang,Nicole A Hawkins,Christopher H Thompson,Erin M Baker,Dennis M Echevarria-Cooper,Levi Barse,Tyler Thenstedt,Conor J Dixon,Nathan Speakes,Alfred L George,Jennifer A Kearney,Nicole A. Hawkins,Christopher H. Thompson,Erin M. Baker,Dennis M. Echevarria-Cooper,Conor J. Dixon,Alfred L. George,Jennifer A. Kearney

DOI: https://doi.org/10.1016/j.nbd.2024.106470

IF: 7.046

2024-05-01

Neurobiology of Disease

Abstract:Pathogenic variants in KCNB1 are associated with a neurodevelopmental disorder spectrum that includes global developmental delays, cognitive impairment, abnormal electroencephalogram (EEG) patterns, and epilepsy with variable age of onset and severity. Additionally, there are prominent behavioral disturbances, including hyperactivity, aggression, and features of autism spectrum disorder. The most frequently identified recurrent variant is KCNB1-p.R306C, a missense variant located within the S4 voltage-sensing transmembrane domain. Individuals with the R306C variant exhibit mild to severe developmental delays, behavioral disorders, and a diverse spectrum of seizures. Previous in vitro characterization of R306C described altered sensitivity and cooperativity of the voltage sensor and impaired capacity for repetitive firing of neurons. Existing Kcnb1 mouse models include dominant negative missense variants, as well as knockout and frameshifts alleles. While all models recapitulate key features of KCNB1 encephalopathy, mice with dominant negative alleles were more severely affected. In contrast to existing loss-of-function and dominant-negative variants, KCNB1-p.R306C does not affect channel expression, but rather affects voltage-sensing. Thus, modeling R306C in mice provides a novel opportunity to explore impacts of a voltage-sensing mutation in Kcnb1. Using CRISPR/Cas9 genome editing, we generated the Kcnb1<sup>R306C</sup> mouse model and characterized the molecular and phenotypic effects. Consistent with the in vitro studies, neurons from Kcnb1<sup>R306C</sup> mice showed altered excitability. Heterozygous and homozygous R306C mice exhibited hyperactivity, altered susceptibility to chemoconvulsant-induced seizures, and frequent, long runs of slow spike wave discharges on EEG, reminiscent of the slow spike and wave activity characteristic of Lennox Gastaut syndrome. This novel model of channel dysfunction in Kcnb1 provides an additional, valuable tool to study KCNB1 encephalopathies. Furthermore, this allelic series of Kcnb1 mouse models will provide a unique platform to evaluate targeted therapies.

neurosciences
Familial KCNQ2 mutation: a psychiatric perspective

Anton Iftimovici,Angeline Charmet,Béatrice Desnous,Ana Ory,Richard Delorme,Charles Coutton,Françoise Devillard,Mathieu Milh,Anna Maruani

DOI: https://doi.org/10.1097/ypg.0000000000000360

2024-01-08

Psychiatric Genetics

Abstract:KCNQ2 mutations can lead to a range of heterogeneous early-onset epileptic syndromes, from self-limited familial neonatal epilepsy to severe neonatal-onset developmental and epileptic encephalopathy. Additional features may include dystonia, spasticity, cortical visual impairment, abnormal eye movements, or feeding intolerance ( Morrison-Levy et al., 2021 ). KCNQ2 is one among the genes coding for KCNQ M-current potassium channels that assemble as heteromers, controlling adaptation of neuronal firing and spike frequency across the brain ( Delmas and Brown, 2005 ; Soh et al., 2022 ). The overall incidence of KCNQ2 -related disorders is estimated at 2.93–3.59 per 100 000 births ( López-Rivera et al., 2020 ). Functional outcome is highly variable with different patterns of seizure activity (some subsequently affecting brain maturation) on the one hand, and altered neurodevelopment on the other, independently of epilepsy. Moreover, different mutations of the KCNQ2 gene can cause the same phenotype ( Milh et al., 2016 ). In this context of heterogeneous genotype/phenotype relationships, the spectrum of KCNQ2 -related neurodevelopment extends from normal cognition to severe motor, behavioral and social impairment ( Symonds et al., 2019 ). However, although the available literature draws an increasingly clearer picture of the various epileptic syndromes and developmental profiles, there is a need to improve our understanding of the socio-behavioral aspects of the disease to inform and prepare families and caregivers. This is especially important in the long-term as seizure frequency usually declines or recedes after childhood, while a high frequency of autistic features and mild to severe intellectual disability (ID) are reported among adults with KCNQ2 encephalopathy ( Boets et al., 2022 ).

genetics & heredity,neurosciences
A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine

Paola Imbrici,Elena Conte,Rikard Blunck,Fabrizia Stregapede,Antonella Liantonio,Michele Tosi,Maria Cristina D’Adamo,Annamaria De Luca,Vesna Brankovic,Ginevra Zanni

DOI: https://doi.org/10.3390/ijms22189913

IF: 5.6

2021-09-14

International Journal of Molecular Sciences

Abstract:Kv1.2 channels, encoded by the KCNA2 gene, are localized in the central and peripheral nervous system, where they regulate neuronal excitability. Recently, heterozygous mutations in KCNA2 have been associated with a spectrum of symptoms extending from epileptic encephalopathy, intellectual disability, and cerebellar ataxia. Patients are treated with a combination of antiepileptic drugs and 4-aminopyridine (4-AP) has been recently trialed in specific cases. We identified a novel variant in KCNA2, E236K, in a Serbian proband with non-progressive congenital ataxia and early onset epilepsy, treated with sodium valproate. To ascertain the pathogenicity of E236K mutation and to verify its sensitivity to 4-AP, we transfected HEK 293 cells with Kv1.2 WT or E236K cDNAs and recorded potassium currents through the whole-cell patch-clamp. In silico analysis supported the electrophysiological data. E236K channels showed voltage-dependent activation shifted towards negative potentials and slower kinetics of deactivation and activation compared with Kv1.2 WT. Heteromeric Kv1.2 WT+E236K channels, resembling the condition of the heterozygous patient, confirmed a mixed gain- and loss-of-function (GoF/LoF) biophysical phenotype. 4-AP inhibited both Kv1.2 and E236K channels with similar potency. Homology modeling studies of mutant channels suggested a reduced interaction between the residue K236 in the S2 segment and the gating charges at S4. Overall, the biophysical phenotype of E236K channels correlates with the mild end of the clinical spectrum reported in patients with GoF/LoF defects. The response to 4-AP corroborates existing evidence that KCNA2-disorders could benefit from variant-tailored therapeutic approaches, based on functional studies.

biochemistry & molecular biology,chemistry, multidisciplinary
Functional consequences of a KCNT1 variant associated with status dystonicus and early-onset infantile encephalopathy

Tracy S Gertler,Christopher H Thompson,Carlos G Vanoye,John J Millichap,Alfred L George Jr

DOI: https://doi.org/10.1002/acn3.50847

Abstract:Objective: We identified a novel de novo KCNT1 variant in a patient with early-infantile epileptic encephalopathy (EIEE) and status dystonicus, a life-threatening movement disorder. We determined the functional consequences of this variant on the encoded KNa 1.1 channel to investigate the molecular mechanisms responsible for this disorder. Methods: A retrospective case review of the proband is presented. We performed manual and automated electrophysiologic analyses of the KCNT1-L437F variant expressed heterologously in Chinese hamster ovary (CHO) cells in the presence of channel activators/blockers. Results: The KCNT1-L437F variant, identified in a patient with refractory EIEE and status dystonicus, confers a gain-of-function channel phenotype characterized by instantaneous, voltage-dependent activation. Channel openers do not further increase L437F channel function, suggesting maximal activation, whereas channel blockers similarly block wild-type and variant channels. We further demonstrated that KCNT1 current can be measured on a high-throughput automated electrophysiology platform with potential value for future screening of novel and repurposed pharmacotherapies. Interpretation: A novel pathogenic variant in KCNT1 associated with early-onset, medication-refractory epilepsy and dystonia causes gain-of-function with rapid activation kinetics. Our findings extend the genotype-phenotype relationships of KCNT1 variants to include severe dystonia.
Evaluation of four KCNMA1 channelopathy variants on BK channel current under CaV1.2 activation

Ria L. Dinsdale,Andrea L. Meredith

DOI: https://doi.org/10.1080/19336950.2024.2396346

2024-09-03

Channels

Abstract:Variants in KCNMA1 , encoding the voltage- and calcium-activated K + (BK) channel, are associated with human neurological disease. The effects of gain-of-function (GOF) and loss-of-function (LOF) variants have been predominantly studied on BK channel currents evoked under steady-state voltage and Ca 2+ conditions. However, in their physiological context, BK channels exist in partnership with voltage-gated Ca 2+ channels and respond to dynamic changes in intracellular Ca 2+ (Ca 2+ i ). In this study, an L-type voltage-gated Ca 2+ channel present in the brain, Ca V 1.2, was co-expressed with wild type and mutant BK channels containing GOF (D434G, N999S) and LOF (H444Q, D965V) patient-associated variants in HEK-293T cells. Whole-cell BK currents were recorded under Ca V 1.2 activation using buffering conditions that restrict Ca 2+ i to nano- or micro-domains. Both conditions permitted wild type BK current activation in response to Ca V 1.2 Ca 2+ influx, but differences in behavior between wild type and mutant BK channels were reduced compared to prior studies in clamped Ca 2+ i . Only the N999S mutation produced an increase in BK current in both micro- and nano-domains using square voltage commands and was also detectable in BK current evoked by a neuronal action potential within a microdomain. These data corroborate the GOF effect of N999S on BK channel activity under dynamic voltage and Ca 2+ stimuli, consistent with its pathogenicity in neurological disease. However, the patient-associated mutations D434G, H444Q, and D965V did not exhibit significant effects on BK current under Ca V 1.2-mediated Ca 2+ influx, in contrast with prior steady-state protocols. These results demonstrate a differential potential for KCNMA1 variant pathogenicity compared under diverse voltage and Ca 2+ conditions.

biochemistry & molecular biology
A novel KCND3 variant in the N-terminus impairs the ionic current of Kv4.3 and is associated with SCA19/22

Marlen Colleen Reis,Laura Mandler,Jun-Suk Kang,Dominik Oliver,Christian Halaszovich,Dagmar Nolte

DOI: https://doi.org/10.1111/jcmm.70039

Abstract:Spinocerebellar ataxias (SCAs) are a genetically heterogeneous group of autosomal dominant movement disorders. Among the SCAs associated with impaired ion channel function, SCA19/22 is caused by pathogenic variants in KCND3, which encodes the voltage-gated potassium channel Kv4.3. SCA19/22 is clinically characterized by ataxia, dysarthria and oculomotor dysfunction in combination with other signs and symptoms, including mild cognitive impairment, peripheral neuropathy and pyramidal signs. The known KCND3 pathogenic variants are localized either in the transmembrane segments, the connecting loops, or the C-terminal region of Kv4.3. We have identified a novel pathogenic variant, c.455A>G (p.D152G), localized in the N-terminus of Kv4.3. It is located in the immediate neighbourhood of the T1 domain, which is responsible for multimerization with the β-subunit KChIP2b and thus for the formation of functional heterooctamers. Electrophysiological studies showed that p.D152G does not affect channel gating, but reduces the ionic current in Kv4.3, even though the variant is not located in the transmembrane domains. Impaired channel trafficking to the plasma membrane may contribute to this effect. In a patient with a clinical picture corresponding to SCA19/22, p.D152G is the first pathogenic variant in the N-terminus of Kv4.3 to be described to date with an effect on ion channel activity.
Roles of KCNA2 in Neurological Diseases: from Physiology to Pathology

Peng, Jing

DOI: https://doi.org/10.1007/s12035-024-04120-9

IF: 5.682

2024-03-23

Molecular Neurobiology

Abstract:Potassium voltage-gated channel subfamily a member 2 (Kv1.2, encoded by KCNA2 ) is highly expressed in the central and peripheral nervous systems. Based on the patch clamp studies, gain-of function (GOF), loss-of-function (LOF), and a mixed type (GOF/LOF) variants can cause different conditions/disorders. KCNA2 -related neurological diseases include epilepsy, intellectual disability (ID), attention deficit/hyperactive disorder (ADHD), autism spectrum disorder (ASD), pain as well as autoimmune and movement disorders. Currently, the molecular mechanisms for the reported variants in causing diverse disorders are unknown. Consequently, this review brings up to date the related information regarding the structure and function of Kv1.2 channel, expression patterns, neuronal localizations, and tetramerization as well as important cell and animal models. In addition, it provides updates on human genetic variants, genotype–phenotype correlations especially highlighting the deep insight into clinical prognosis of KCNA2 -related developmental and epileptic encephalopathy, mechanisms, and the potential treatment targets for all KCNA2 -related neurological disorders.

neurosciences
High-throughput Evaluation of Epilepsy-associated KCNQ2 Variants Reveals Functional and Pharmacological Heterogeneity

Carlos G. Vanoye,Reshma R. Desai,Zhigang Ji,Sneha Adusumilli,Nirvani Jairam,Nora Ghabra,Nishtha Joshi,Eryn Fitch,Katherine Helbig,Dianalee McKnight,Amanda Lindy,Fanggeng Zou,Ingo Helbig,Edward Cooper,Alfred L. George

DOI: https://doi.org/10.1101/2021.10.18.464842

2021-10-19

Abstract:ABSTRACT Hundreds of KCNQ2 variants have been identified by genetic testing of children with early onset epilepsy and/or developmental disability. Voltage-clamp recording from heterologous cells has proved useful for establishing deleterious functional effects of KCNQ2 variants, but procedures adapting these assays for standardized, higher throughput data collection and reporting are lacking. In this study, we employed automated patch clamp recording to assess in parallel the functional and pharmacological properties of 79 missense and 2 in-frame deletion variants of KCNQ2 . Among the variants we studied were a training set of 18 pathogenic variants previously studied by voltage-clamp recording, 24 mostly rare population variants, and 39 disease-associated variants with unclear functional effects. Variant KCNQ2 subunits were transiently expressed in a cell line stably expressing KCNQ3 to reconstitute the physiologically relevant channel complex. Variants with severe loss-of-function were also co-expressed 1:1 with WT KCNQ2 in the KCNQ3 cell line to mimic the heterozygous genotype and assess dominant-negative behavior. In total, we analyzed electrophysiological data recorded from 9,480 cells. The functional properties of WT KCNQ2/KCNQ3 channels and pharmacological responses to known blockers and activators determined by automated patch clamp recording were highly concordant with previous findings. Similarly, functional properties of 18 known pathogenic variants largely matched previously published results and the validated automated patch clamp assay. Many of the 39 previously unstudied disease-associated KCNQ2 variants exhibited prominent loss-of-function and dominant-negative effects, providing strong evidence in support of pathogenicity. All variants, exhibit response to retigabine (10 μM), although there were differences in maximal responses. Variants within the ion selectivity filter exhibited the weakest responses whereas retigabine had the strongest effect on gain-of-function variants in the voltage-sensor domain. Our study established a high throughput method to detect deleterious functional consequences of KCNQ2 variants. We demonstrated that dominant-negative loss-of-function is a common mechanism associated with missense KCNQ2 variants but this does not occur with rare population variation in this gene. Importantly, we observed genotype-dependent differences in the response of KCNQ2 variants to retigabine.

Abdominal Pregnancy: Discussion, classification, and case presentation

A novel loss-of-function KCNB1 gene variant in a twin with global developmental delay and seizures

A Novel Mutation in KCNQ2 Gene Causes Benign Familial Neonatal Convulsions in a Chinese Family

Autosomal Dominant Sleep-Related Hypermotor Epilepsy Associated with a Novel Mutation of KCNT1.

KCNQ1 Gain-of-function Mutation in Familial Atrial Fibrillation

Metabolism of 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(R)-HETE) in corneal tissues: formation of novel metabolites.

A novel KCNQ2 missense variant in non-syndromic intellectual disability causes mild gain-of-function of Kv7.2 channel

A Novel Kv7.3 Variant in the Voltage-Sensing S4 Segment in a Family With Benign Neonatal Epilepsy: Functional Characterization and in vitro Rescue by β-Hydroxybutyrate

Mono-allelic KCNB2 variants lead to a neurodevelopmental syndrome caused by altered channel inactivation

Impaired excitability of fast-spiking neurons in a novel mouse model of KCNC1 epileptic encephalopathy

A KCNC1 Variant Linked to Rett Syndrome Disrupts ER to Golgi Trafficking of Kv3.1 Channel

Etiological involvement of KCND1 variants in an X-linked neurodevelopmental disorder with variable expressivity

Electrophysiological Characterization Reveals a Complex Phenotype Affecting the Slow Delayed Rectifier Potassium Current (IKs) Voltage Dependence by Causing a Hyperpolarizing Shift and a Lack of Response to Protein Kinase A Activation

Altered neurological and neurobehavioral phenotypes in a mouse model of the recurrent KCNB1-p.R306C voltage-sensor variant

Familial KCNQ2 mutation: a psychiatric perspective

A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine

Functional consequences of a KCNT1 variant associated with status dystonicus and early-onset infantile encephalopathy

Evaluation of four KCNMA1 channelopathy variants on BK channel current under CaV1.2 activation

A novel KCND3 variant in the N-terminus impairs the ionic current of Kv4.3 and is associated with SCA19/22

Roles of KCNA2 in Neurological Diseases: from Physiology to Pathology

High-throughput Evaluation of Epilepsy-associated KCNQ2 Variants Reveals Functional and Pharmacological Heterogeneity